A carregar...
High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease
BACKGROUND AND AIM: While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. METHODS: Primary aims of this study were to determine the frequency of excess weight gain (body mass index [BMI...
Na minha lista:
| Publicado no: | JGH Open |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Publishing Asia Pty Ltd
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7273726/ https://ncbi.nlm.nih.gov/pubmed/32514452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12277 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|